Content related to Cancer Can Run But it Can’t Hide

Acute lymphoblastic leukemia (ALL) affects about 3,000 children each year in the United States. In one tenth of cases, the cancer resists treatment. Yong-Mi Kim, MD, PhD, MPH investigates just how

Research at Children’s Hospital Los Angeles enables a novel compound to achieve a key designation from the Food and Drug Administration.

Yves De Clerck, MD

5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation

Samantha is a PhD student exploring a potential therapeutic target in drug-resistant leukemia.

A fourth-year PhD candidate, Heather is researching the role of integrin beta-1 in pediatric acute myeloid leukemia

In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to